Medicines, Poisons and Therapeutic Goods Regulation 2026
177Use and disclosure of information by authorised practitioners and pharmacists
Start here
Get a plain-English read of 177
Turn the raw legal text into a practical explanation grounded in Medicines, Poisons and Therapeutic Goods Regulation 2026.
177 Use and disclosure of information by authorised practitioners and pharmacists
177 Use and disclosure of information by authorised practitioners and pharmacists
(1) A medical practitioner, nurse practitioner, registered nurse with an endorsement, pharmacist or dentist (a relevant person) may access, use and disclose information in the database for the following purposes—
(a) to provide treatment to a patient by—
(i) reviewing the prescribing of monitored medicines to the patient by other authorised practitioners, and
(ii) reviewing the supply of monitored medicines to the patient by pharmacists,
(b) to provide advice to an authorised practitioner or pharmacist on the treatment of a patient.
(2) A relevant person other than a pharmacist may access, use and disclose information in the database as follows—
(a) for the purposes of applying for or reviewing an approval or OTP registration,
(b) in relation to the revocation of an approval or OTP registration by the Health Secretary.
(3) A pharmacist may access, use and disclose information in the database as follows—
(a) for the purposes of applying for or reviewing an approval or OTP registration that relates to the supply or administration of a scheduled substance by the pharmacist,
(b) in relation to the revocation of an approval or OTP registration that relates to the supply or administration of a scheduled substance by the pharmacist.